-+ 0.00%
-+ 0.00%
-+ 0.00%

Unfortunately, the provided text does not contain a title for the article. It appears to be a financial report or a set of financial statements, but it does not have a title. If you can provide more context or information about the article, I may be able to help you generate a title.

Press release·08/15/2026 07:31:02
Listen to the news
Unfortunately, the provided text does not contain a title for the article. It appears to be a financial report or a set of financial statements, but it does not have a title. If you can provide more context or information about the article, I may be able to help you generate a title.

Unfortunately, the provided text does not contain a title for the article. It appears to be a financial report or a set of financial statements, but it does not have a title. If you can provide more context or information about the article, I may be able to help you generate a title.

I apologize, but the provided text appears to be a financial report in a machine-readable format, likely in XBRL (eXtensible Business Reporting Language). It contains a large amount of data and financial information, but it is not easily summarized in a single paragraph.

However, I can try to provide a brief overview of the report’s key financial figures and main events. The report appears to be a quarterly financial report for a company, covering the period from January 1, 2026, to June 30, 2026. The report includes financial statements, such as the balance sheet, income statement, and cash flow statement, as well as notes to the financial statements.

The report also includes information on the company’s stock, including the number of shares outstanding and the stock’s fair value. Additionally, the report provides information on the company’s related-party transactions, including transactions with QuartaRad Inc. and Sellavir Inc.

If you would like a more detailed summary of the report, please let me know and I can try to provide one.

Quarta-Rad’s Shift Towards AI-Driven Software Solutions

Quarta-Rad, a company that was initially formed to distribute and sell radiation detection devices, has undergone a significant transformation in recent years. The company has shifted its primary business focus towards software development and AI-driven technologies, reducing its emphasis on its historical radiation detection product line.

Acquisition of Sellavir and the CenterEye Platform

In December 2020, Quarta-Rad acquired Sellavir, Inc., an AI software company focused on advanced analytics, image processing, and call center software solutions. Sellavir has developed CenterEye, a software platform designed to simplify the use and management of cloud-based call center systems. CenterEye is intended to enhance call center operations through AI-driven analytics, automation, and operational monitoring capabilities.

Reliance on Related Party Transactions

Substantially all of Quarta-Rad’s revenue is currently generated through its relationship with Star Systems Corporation (STAR), a Japanese entity of which the company’s Chief Executive Officer and majority shareholder is also the majority shareholder. This revenue is derived from software development and consulting services provided to STAR, and the pricing and volume of these arrangements have not been established through arm’s-length negotiation. The company has no contractual commitment from STAR with respect to future volumes, and STAR may reduce or discontinue its engagement of Sellavir at any time. The loss of this relationship would eliminate substantially all of Quarta-Rad’s revenue, and investors should not assume that historical revenue from STAR is indicative of the company’s ability to generate revenue from unaffiliated customers.

Financial Performance

Quarta-Rad has experienced recurring operating losses, primarily due to limited revenues. The company’s current financial conditions and recurring losses raise substantial doubt about its ability to continue as a going concern. Management intends to fund operations through existing cash balances, revenues generated from operations, related party support, and, if necessary, additional capital raises or strategic financing arrangements.

Three Months Ended June 30, 2026 vs. Three Months Ended June 30, 2025

  • Revenues decreased by 5.16% to $63,856, primarily due to the phase-out of Quarta-Rad sales and the timing of consulting projects and revenue recognized by Sellavir.
  • Cost of goods sold increased by 46.00% to $43,220, primarily due to the classification of contractors and timing of expense recognition in Sellavir.
  • Operating expenses decreased by 59.09% to $50,856, primarily attributable to a decrease in administrative expenses and professional fees.
  • Net loss decreased by 51.75% to $34,785, primarily due to the decrease in administrative expenses.

Quarta-Rad Segment

  • Revenues decreased by 63.26% to $856, primarily due to the phase-out of Quarta-Rad sales.
  • Cost of goods sold decreased by 100.00% to $0, as a result of decreased sales.
  • Operating expenses decreased by 65.94% to $19,913, primarily due to the decrease in administrative expenses.
  • Net loss decreased by 66.35% to $19,057, primarily due to the decrease in administrative expenses.

Sellavir Segment

  • Revenues decreased by 3.08% to $63,000, due to the decrease in Sellavir revenue recognition.
  • Cost of goods sold increased by 48.44% to $43,220, primarily due to the classification of contractors and timing of expense recognition in Sellavir.
  • Operating expenses decreased by 53.00% to $30,943, primarily due to a decrease in administrative expenses.
  • Net loss increased by 1.64% to $15,728, primarily due to an increase in foreign currency translation loss.

Six Months Ended June 30, 2026 vs. Six Months Ended June 30, 2025

  • Revenues decreased by 10.48% to $89,712, primarily due to the phase-out of Quarta-Rad sales and the timing of consulting projects and revenue recognized by Sellavir.
  • Cost of goods sold decreased by 1.55% to $62,860, primarily due to the decrease in sales.
  • Operating expenses decreased by 28.58% to $152,003, primarily attributable to the decrease in administrative expenses.
  • Net loss decreased by 7.05% to $138,963, primarily due to the decrease in administrative expenses.

Quarta-Rad Segment

  • Revenues decreased by 67.18% to $1,712, primarily due to the phase-out of Quarta-Rad sales.
  • Cost of goods sold decreased by 100.00% to $0, as a result of decreased sales.
  • Operating expenses decreased by 44.36% to $55,781, primarily due to the decrease in administrative expenses.
  • Net loss decreased by 44.75% to $54,069, primarily due to the decrease in administrative expenses.

Sellavir Segment

  • Revenues decreased by 7.37% to $88,000, due to the decrease in Sellavir revenue recognition.
  • Cost of goods sold increased by 3.03% to $62,860, primarily due to the classification of contractors and timing of expense recognition in Sellavir.
  • Operating expenses decreased by 14.54% to $96,222, primarily due to a decrease in administrative expenses.
  • Net loss increased by 64.39% to $84,894, primarily due to an increase in foreign currency translation loss and administrative expenses.

Liquidity and Capital Resources

  • As of June 30, 2026, Quarta-Rad had $38,528 in cash and a note receivable and related accrued interest due from a related party Thai corporation of $302,367.
  • The company’s working capital deficit was $309,030 as of June 30, 2026, indicating a need for additional funding to support operations.
  • Quarta-Rad used $34,381 in cash for operating activities during the six months ended June 30, 2026.
  • The company has no formal long-term lines of credit or other bank financing arrangements and no current plans for the purchase or sale of any plant or equipment or changes in the number of employees.

Outlook and Future Plans

Quarta-Rad’s business strategy has evolved to focus on the development and commercialization of CenterEye, its proprietary AI-driven call center software platform. The company aims to enhance call center efficiency, operational visibility, and customer engagement through advanced analytics, automation, and monitoring solutions.

Over the next twelve months, Quarta-Rad plans to:

  1. Software Development: Continue investing in the development and enhancement of CenterEye to meet the evolving needs of the call center industry.
  2. Marketing: Increase marketing efforts to generate additional leads, reseller opportunities, and customer relationships for CenterEye and related software solutions.
  3. Partnerships and Client Acquisition: Pursue strategic relationships with call center operators, technology providers, and resellers to demonstrate the effectiveness of CenterEye and support future recurring revenue opportunities.

While the company continues to maintain limited activities associated with its historical radiation detection product business, management’s primary operational focus has shifted toward AI-driven software and analytics solutions.

Conclusion

Quarta-Rad’s transformation from a radiation detection product company to a software and AI-driven technology firm presents both opportunities and challenges. The company’s reliance on a related party for the majority of its revenue raises concerns about the sustainability of its business model and the ability to generate revenue from unaffiliated customers.

The successful development and commercialization of CenterEye will be crucial to Quarta-Rad’s future success, as the company seeks to leverage its AI capabilities and expand its presence in the call center software industry. However, the company’s recurring losses and working capital deficit highlight the need for additional funding and strategic partnerships to support its long-term growth and viability.

Investors should closely monitor Quarta-Rad’s progress in diversifying its revenue streams, establishing strategic relationships, and demonstrating the commercial viability of its AI-driven software solutions. The company’s ability to navigate the competitive landscape and address its going concern considerations will be key factors in determining its future prospects.